(Q34395356)

1 August 2017

title

Effects of peroxisome proliferator-activated receptor alpha/delta agonists on HDL-cholesterol in vervet monkeys (English)

1 reference

1 August 2017

Jeanne M Wallace

1

1 reference

1 August 2017

Margrit Schwarz

2

1 reference

1 August 2017

Peter Coward

3

1 reference

1 August 2017

Jonathan Houze

4

1 reference

1 August 2017

Janet K Sawyer

5

1 reference

1 August 2017

Kathryn L Kelley

6

1 reference

1 August 2017

Anne Chai

7

1 reference

1 August 2017

Lawrence L Rudel

8

1 reference

1 August 2017

publication date

16 February 2005

1 reference

Journal of Lipid Research

1 August 2017

published in

1 reference

1 August 2017

volume

46

1 reference

1 August 2017

issue

5

1 reference

1 August 2017

page(s)

1009-1016

1 reference

The role of PPARs in atherosclerosis

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500002-JLR200

Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500002-JLR200

Effects of peroxisome proliferator-activated receptor-gamma agonists on central nervous system inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500002-JLR200

Emerging roles of PPARs in inflammation and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500002-JLR200

A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500002-JLR200

PPARdelta is a very low-density lipoprotein sensor in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500002-JLR200

PPAR agonists in the treatment of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500002-JLR200

Compared with dietary monounsaturated and saturated fat, polyunsaturated fat protects African green monkeys from coronary artery atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500002-JLR200

Lipoprotein and cholesterol metabolism in diet-induced coronary artery atherosclerosis in primates. Role of cholesterol and fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500002-JLR200

T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500002-JLR200

Regulation of reverse cholesterol transport and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500002-JLR200

The peroxisome proliferator-activated receptor delta promotes lipid accumulation in human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500002-JLR200

Activation of PPARdelta alters lipid metabolism in db/db mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500002-JLR200

Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500002-JLR200

Metabolism of high density lipoprotein subfractions

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500002-JLR200

Regulation of apo A-I gene expression by fibrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500002-JLR200

Lipolysis of triglyceride-rich lipoproteins generates PPAR ligands: evidence for an antiinflammatory role for lipoprotein lipase

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500002-JLR200

PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500002-JLR200

Fibrates down-regulate hepatic scavenger receptor class B type I protein expression in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500002-JLR200

Transcriptional repression of atherogenic inflammation: modulation by PPARdelta

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500002-JLR200

Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500002-JLR200

Lipoprotein lipase and hepatic lipase: their relationship with HDL subspecies Lp(A-I) and Lp(A-I,A-II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500002-JLR200

The nuclear receptors peroxisome proliferator-activated receptor alpha and Rev-erbalpha mediate the species-specific regulation of apolipoprotein A-I expression by fibrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500002-JLR200

Reduction of atherosclerosis by the peroxisome proliferator-activated receptor alpha agonist fenofibrate in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500002-JLR200

CLA-1/SR-BI Is Expressed in Atherosclerotic Lesion Macrophages and Regulated by Activators of Peroxisome Proliferator-Activated Receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M500002-JLR200

10.1194/JLR.M500002-JLR200

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference